Biologics for evaluating drug targets: an interview with Michael Schwenkert
In this interview, Michael Schwenkert (Bio-Rad Laboratories; CA, USA) discusses the use of neo-epitope specific antibodies in the field of drug discovery and development.
In this interview, Michael Schwenkert (Bio-Rad) talks to Bioanalysis Zone about the poster he presented at EBF 2017 (Barcelona, Spain). Learn more about the use of antibodies to evaluate drug targets and the development of neo-epitope specific antibodies at Bio-Rad.
Did you enjoy this interview? You may also like: